Skip to main content
SpringerLink
Log in

Leukotrienes and macrophage activation: Augmented cytotoxic activity and enhanced interleukin 1, tumor necrosis factor and hydrogen peroxide production

  • Cytokines and Macrophage Activation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Leukotrienes (LT), and in particular LTB4, are potent inflammatory mediators and immunomodulators. In its interactions with leukocytes, LTB4 can activate numerous functions of neutrophils and modulate the activities of various lymphocyte subsets. LTB4 can also augment macrophage and monocyte cytotoxic activities and enhance their production of hydrogen peroxide and the monokines interleukin 1 and tumor necrosis factor. These observations allow a more detailed understanding of the effects of LTB4 on cellular immune and inflammatory functions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. B. Samuelsson,Leukotrienes: a new class of mediators of immediate hypersensitivity reaction and inflammation. InAdvances in Prostaglandin, Thromboxane and Leukotriene research. (Ed. B. Samuelsson, R. Paoletti and P. W. Ramwell) p. 1, Raven Press, New York 1983.

    Google Scholar 

  2. M. A. Bray, A. W. Ford-Hutchinson and J. H. Smith,Leukotriene B 4 an inflammatory mediator in vivo. Prostaglandins22, 213 (1981).

    PubMed  Google Scholar 

  3. M. Rola-Pleszczynski,Immunoregulation by leukotrienes and other lipoxygenase metabolites. Immunol. Today6, 302–307 (1985).

    Google Scholar 

  4. D. O. Adams and T. A. Hamilton,The cell biology of macrophage activation. Am. Rev. Immunol.2, 283–318 (1984).

    Google Scholar 

  5. J. J. Rinehart, P. Lange, B. J. Gormus and M. E. Kaplan,Human monocyte-induced tumor cell cytotoxicity. Blood52, 211–220 (1978).

    PubMed  Google Scholar 

  6. D. O. Adams and P. A. Marino,Evidence for a multistep mechanism of cytolysis by BCG-activated macrophages: the interrelationship between the capacity of cytolysis, target binding and secretion of cytolytic factor. J. Immunol.126, 981–987 (1981).

    PubMed  Google Scholar 

  7. S. D. Somers, J. P. Mastin and D. O. Adams,The binding of tumor cells by murine mononuclear phagocytes can be divided into two qualitatively distinct types. J. Immunol.131, 2086–2093 (1983).

    PubMed  Google Scholar 

  8. D. O. Adams,Effector mechanisms of cytolytically activated macrophages: 1. Secretion of neutral proteases and effect of protease inhibitors. J. Immunol.124, 286–292 (1980).

    PubMed  Google Scholar 

  9. G. A. Currie,Activated macrophages kill tumor cells by releasing arginase. Nature273, 758–759 (1978).

    PubMed  Google Scholar 

  10. J. Ferluga, H. V. Schorlemmer, L. C. Baptista and A. C. Allison,Production of the complete cleavage product C3a, by activated macrophages and its tumorolytic effects. Clin. Exp. Immunol.31, 512–517 (1978).

    PubMed  Google Scholar 

  11. C. F. Nathan, S. C. Silverstein, L. H. Brukner and Z. A. Cohn,Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J. Exp. Med.149, 84–89 (1979).

    PubMed  Google Scholar 

  12. C. F. Nathan, B. A. Arrick, H. W. Murray, N. M. Desantis and Z. A. Cohn,Tumor cell anti-oxidant defenses. Inhibition of the glutathione redox cycle enhances macrophage-mediated cytolysis. J. Exp. Med.153, 766–782 (1980).

    Google Scholar 

  13. M. K. Cathcart, D. W. Morel and G. M. Chisolm,III. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J. of Leuk. Biol.38, 341–350 (1985).

    Google Scholar 

  14. N. Matthews,Production of an anti-tumor cytotoxin by human monocytes. Immunol.44, 135–142 (1981).

    Google Scholar 

  15. A. R. Chen, K. P. McKinnon and H. S. Korin,Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor. J. Immunol.135, 3978–3987 (1985).

    PubMed  Google Scholar 

  16. R. S. Kornbluth and T. S. Edgington,Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF- mediated cellular cytotoxicity by endotoxin. J. Immunol.137, 2585–2591 (1986).

    PubMed  Google Scholar 

  17. R. Feinman, D. Henriksen-Destefano, M. Tsujimoto and J. Vilcek,Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes. J. Immunol.138, 635–640 (1987).

    PubMed  Google Scholar 

  18. S. Graves and B. Bonavida,Early events in tumor necrosis factor (TNF)-mediated cytotoxicity. Fed. Proc.46, 765 (1987).

    Google Scholar 

  19. V. Ruggiero, K. Latham and C. Bablioni,Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells. J. Immunol.138, 2711–2717 (1987).

    PubMed  Google Scholar 

  20. K. Onozaki, K. Matsushima, E. S. Kleinerman, T. Saito and J. J. Oppenheim,Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity. J. Immunol.135, 314–320 (1985).

    PubMed  Google Scholar 

  21. R. Jett, A. Mantovani and R. B. Herberman,Augmentation of human-monocyte-mediated cytolysis by interferon. Cell. Immunol.54, 425–434 (1980).

    PubMed  Google Scholar 

  22. R. M. Schultz,Synergistic activation of macrophages by lymphokine and lipopolysaccharide: evidence for lymphokine as the primer and interferon as the trigger. J. Interferon Res.2, 459–466 (1982).

    PubMed  Google Scholar 

  23. E. J. Léonard, L. P. Ruco and M. S. Mcltzer,Characterization of macrophage activation factor, a lymphokine that causes macrophages to become cytotoxic for tumor cells. Cell. Immunol.41, 347–357 (1978).

    PubMed  Google Scholar 

  24. E. J. Wing, A. Waheed, R. K. Shadduck, L. S. Nagle and Stephenson,Effect of colony-stimulating factor on murine macrophages. Induction of antitumor activity. J. Clin. Invest.69, 270–276 (1982).

    PubMed  Google Scholar 

  25. M. J. Thomassen, B. Barna, S. Malcolm-Kohn, M. Farmer, G. Urda, H. Wiedemann and M. Ahmad,C-reactive protein (CRP) enhances tumoricidal activity of human alveolar macrophages. Fed. Proc.46, 1502 (1987).

    Google Scholar 

  26. R. M. Schultz, N. A. Pavlidis, W. A. Stylos and M. A. Chirigos,Regulation of macrophage tumoricidal function: A role for prostaglandins of the E series. Science202, 320–327 (1978).

    PubMed  Google Scholar 

  27. S. Taffet and S. W. Russel,Macrophage-mediated tumor cell killing: Regulation of expression of cytolytic activity by prostaglandin E. J. Immunol.126, 424–429 (1981).

    PubMed  Google Scholar 

  28. W. C. Koff and M. A. Dunegan,Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones. J. Immunol.135, 350–354 (1985).

    PubMed  Google Scholar 

  29. M. Rola-Pleszczynski, L. Gagnon and P. Sirois,Leukotriene B 4 augments human natural cytotoxic cell activity. Biochem. Biophys. Res. Commun.113, 531–537 (1983).

    PubMed  Google Scholar 

  30. M. Rola-Pleszczynski, L. Gagnon and P. Sirois,Natural cytotoxic cell activity enhanced by leukotriene B 4:Modulation by cyclooxygenase and lipoxygenase inhibitors. InIcosanoids and Cancer pp. 235–242 (Eds: H. Thaler-Dao, A. Crastes de Paulet et R. Paoletti). Raven Press, New York 1984.

    Google Scholar 

  31. L. Gagnon, P. Sirois and M. Rola-Pleszczynski,Leukotriene B 4 augments natural cytotoxicity by increasing effector to target binding and by inducing the production of a cytotoxic lymphokine. Fed. Proc.43, 1989 (1984).

    Google Scholar 

  32. L. Gagnon, M. Girard, A. K. Sullivan and M. Rola-Pleszczynski,Augmentation of human natural cytotoxic cell activity by leukotriene B 4 mediated by enhanced effectortarget cell binding and increased lytic efficiency. Cell. Immunol.110, 243–252 (1987).

    PubMed  Google Scholar 

  33. C. A. Rouzer, W. A. Scott, A. Z. Cohn, P. Blackburn and J. M. Manning,Mouse peritoneal macrophages release leukotriene C in response to a phagocytic stimulus. Proc. Natl. Acad. Sci (USA)77, 4928 (1980).

    Google Scholar 

  34. C. A. Rouzer, W. A. Scott, A. L. Hamill and Z. A. Cohn,Synthesis of leukotriene C and other arachidonic acid metabolites by mouse pulmonary macrophages. J. Exp. Med.155, 720–733 (1982).

    PubMed  Google Scholar 

  35. A. D. Fels, N. A. Pawlowski, E. B. Cramer, T. K. King, Z. A. Cohn and W. A. Scott,Human alveolar macrophages produce leukotriene B 4. Proc. Natl. Acad. Sci (USA)79, 7866–7870 (1982).

    Google Scholar 

  36. R. Ophir, S. Ben-Efraim and I. L. Bonta,Leukotriene D 4 and indomethacin enhance additively the macrophage cytostatic activity in vitro towards MOPC-315 tumor cells. Int. J. Tiss. Reac.9, 189–194 (1987).

    Google Scholar 

  37. M. Rola-Pleszczynski and I. Lemaire,Leukotrienes augment interleukin 1 production by human monocytes. J. Immunol.135, 3958–3961 (1985).

    PubMed  Google Scholar 

  38. C. A. Dinarello, I. Bishai, L. J. Rosenwasser and F. Coceani,The influence of lipoxygenase inhibitors on the in vitro production of human leukocytic pyrogen and lymphocyte activating factor (interleukin 1). Int. J. Immunopharmacol.1, 43–50 (1984).

    Google Scholar 

  39. M. Rola-Pleszczynski, L. Bouvrette, D. Gingras and M. Girard,Identification of interferon-γ as the lymphokine that mediates leukotriene B4-induced immunoregulation. I. Immunol.139, 513–517 (1987).

    Google Scholar 

  40. L. Gagnon, L. Fillion and M. Rola-Pleszczynski,Leukotriene B4 augments tumor necrosis factor production by human monocytes. Fed. Proc.46 (4), 6253 (1987).

    Google Scholar 

  41. N. Feuerstein, M. Foegh and P. W. Ramwell,Leukotrienes C4 and D4 induce prostaglandin and thromboxane release from rat peritoneal macrophages. Br. J. Pharmacol.72, 389–391 (1981).

    PubMed  Google Scholar 

  42. E. J. Schenkelaars and I. L. Bonta,Effect of leukotriene C4 on the release of secretory products by elicited populations of rat peritoneal macrophages. Eur. J. Pharmacol.86, 477–480 (1983).

    PubMed  Google Scholar 

  43. E. J. Schenkelaars and I. L. Bonta,Cyclooxygenase inhibitors promote leukotriene C4-induced release of beta-glucuronidase from rat peritoneal macrophages prostaglandin E2 suppresses. Int. J. Immunopharmacol.8, 305–311 (1986).

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. L. Gagnon

    Present address: , 8, Robinwood, app. 4, Jamaica Plain, 02130, Boston, MA, USA

Authors and Affiliations

  1. Department of Microbiology and Immunology, Faculty of Health Sciences, University of Ottawa, K1H 8M5, Ottawa, Ontario, Canada

    L. G. Filion

  2. Immunology Division, Faculty of Medicine, University of Sherbrooke, 3001, 12th north avenue, J1H 5N4, Sherbrooke, Québec, Canada

    L. Gagnon, C. Dubois & M. Rola-Pleszczynski

Authors
  1. L. Gagnon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. G. Filion
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Dubois
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Rola-Pleszczynski
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gagnon, L., Filion, L.G., Dubois, C. et al. Leukotrienes and macrophage activation: Augmented cytotoxic activity and enhanced interleukin 1, tumor necrosis factor and hydrogen peroxide production. Agents and Actions 26, 141–147 (1989). https://doi.org/10.1007/BF02126587

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02126587

Keywords

Search

Navigation